Interim report on London case shows no evidence of contamination.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional information
chief executive, UK Medicines and Healthcare Products Regulatory Agency
Related links
Related links
Related links in Nature Research
Related external links
Rights and permissions
About this article
Cite this article
Hopkin, M. Drug to blame for clinical-trial disaster?. Nature (2006). https://doi.org/10.1038/news060503-8
Published:
DOI: https://doi.org/10.1038/news060503-8
This article is cited by
-
Post-translational modifications in the context of therapeutic proteins
Nature Biotechnology (2006)